Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-01-28FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
FDA approved Walgreens' supplemental application for NICOTINE POLACRILEX MINT gum (nicotine polacrilex) as a nicotine replacement product.
-
FDA approval · 2013-01-28FDA Approved: RUGBY NICOTINE POLACRILEX GUM, COATED MINT FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application from Rugby Laboratories to add a coated mint flavor to Rugby Nicotine Polacrilex Gum, a nicotine rep…
-
FDA approval · 2013-01-28FDA Approved: RUGBY NICOTINE POLACRILEX GUM, COATED MINT FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Coated Mint Flavor, from Rugby Laboratories. The approval expands…
-
FDA approval · 2013-01-28FDA Approved: NICOTINE — Supplemental Application (Lucy Goods, Inc.)
The FDA has approved a supplemental application for nicotine polacrilex (nicotine gum) from Lucy Goods, Inc.
-
FDA approval · 2013-01-28FDA Approved: NICOTINE POLACRILEX — Supplemental Application (Walgreens)
FDA approved Walgreens' supplemental application for NICOTINE POLACRILEX, granting an additional approval for this nicotine replacement ther…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-01-28FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)
FDA approved a supplemental application for NICOTINE (nicotine polacrilex) submitted by P & L Development, LLC under ANDA079044. This indica…
-
FDA approval · 2013-01-28FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor, a nicotine replacement therapy intended to aid s…
-
CLINICAL_TRIALS research · 2013-01-08Clinical Trial Update: Researching the Youth Smoking Experience [Phase 1]
Phase 1 clinical trial from Virginia Commonwealth University studying youth smoking has completed.
-
CLINICAL_TRIALS research · 2013-01-03Clinical Trial Update: A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis [NA]
This completed usability study evaluated a smoking-cessation decision aid in people with a recent first episode of psychosis.
-
CLINICAL_TRIALS trial_result · 2012-12-26Clinical Trial Update: Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype [Phase 3]
Phase 3 trial evaluating a genotype-guided, tailored smoking cessation treatment algorithm; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: CogEcig: Cognitive Functioning and Electronic Cigarette [NA]
CogEcig is a trial investigating cognitive functioning in relation to electronic cigarette use for tobacco use disorder, and the study has c…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia [Phase 2]
Phase 2 trial evaluating whether contingent incentives plus bupropion improves smoking cessation in people with schizophrenia; results have …
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes [NA]
This clinical trials entry reports a completed study evaluating the pharmacokinetics of nicotine and other toxic substances associated with …
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving [Phase 2]
Phase 2 trial assessing a nicotine lozenge for relief of provoked acute craving in smoking and smoking cessation.
-
FDA approval · 2012-11-29FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for Equate Nicotine gum (nicotine polacrilex) from Wal-Mart Stores Inc., confirming market autho…
-
FDA approval · 2012-11-29FDA Approved: DG HEALTH NICOTINE — Supplemental Application (Dolgencorp Inc)
FDA approved a supplemental application for DG HEALTH NICOTINE (nicotine polacrilex) from Dolgencorp Inc.
-
FDA approval · 2012-11-29FDA Approved: NICOTINE — Supplemental Application (H E B)
FDA approved a supplemental application for NICOTINE products (NICOTINE and NICOTINE POLACRILEX) from H E B under an ANDA.
-
FDA approval · 2012-11-29FDA Approved: GOOD NEIGHBOR PHARMACY NICOTINE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Nicotine (nicotine polacrilex) from AmerisourceBergen.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: tDCS as Add on Therapy for Treatment of Tobacco Dependence by Standardized Behaviour Therapy [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating transcranial direct current stimulation (tDCS) as an add-on to stand…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Cognitive Behaviour Therapy and Nicotine Replacement to Increase Tobacco Cessation [NA]
A clinical trial evaluated combining Cognitive Behaviour Therapy with Nicotine Replacement to promote tobacco cessation. The study status is…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Efficacy of a Mobile Application in the Smoking Cessation Among Young People [NA]
This document reports on a clinical trial evaluating the efficacy of a mobile application to aid smoking cessation among young people. The s…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Trial Comparing Different Methods of Support With Stopping Smoking (PORTSSS/Stop Together Trial) [Phase 4]
A Phase 4 clinical trial update from the University of Nottingham comparing different support methods to help people stop smoking; the PORTS…
-
FDA approval · 2012-10-09FDA Approved: NICOTINE MINI — Original Application (Walgreen Company)
FDA approves Walgreen Company's NICOTINE MINI (nicotine polacrilex) as an original ANDA, adding a generic nicotine replacement lozenge to th…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Evaluating a Telemedicine Smoking Cessation Program in Rural Primary Care Practices [Phase 3]
A Phase 3 clinical trial evaluated a telemedicine smoking cessation program delivered through rural primary care practices; the study has co…
-
FDA approval · 2012-09-28FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) from Strategic Sourcing Services LLC.